616 related articles for article (PubMed ID: 24664136)
21. Nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification after total hip arthroplasty.
Nilsson OS
Semin Arthroplasty; 1992 Jul; 3(3):172-7. PubMed ID: 10147776
[TBL] [Abstract][Full Text] [Related]
22. Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis.
Kan SL; Yang B; Ning GZ; Chen LX; Li YL; Gao SJ; Chen XY; Sun JC; Feng SQ
Medicine (Baltimore); 2015 May; 94(18):e828. PubMed ID: 25950691
[TBL] [Abstract][Full Text] [Related]
23. The Reduction of Heterotopic Ossification Incidence After Hip Arthroscopy in Patients Treated With Selective Cyclooxygenase 2 Inhibitor (Celecoxib).
Dow T; King JP; Wong IH
Arthroscopy; 2020 Feb; 36(2):453-461. PubMed ID: 31734042
[TBL] [Abstract][Full Text] [Related]
24. Diclofenac for prophylaxis of heterotopic ossification after hip arthroplasty: a systematic review.
Haffer H; Müller M; Ascherl R; Perka C; Winkler T
Hip Int; 2022 Mar; 32(2):144-151. PubMed ID: 33272062
[TBL] [Abstract][Full Text] [Related]
25. Preoperative versus postoperative radiotherapy for prevention of heterotopic ossification (HO): first results of a randomized trial in high-risk patients.
Seegenschmiedt MH; Martus P; Goldmann AR; Wölfel R; Keilholz L; Sauer R
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):63-73. PubMed ID: 8083130
[TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatory Prophylaxis Prevents Heterotopic Ossification in Contralateral Side Hip Arthroscopy: A Case Report.
Warschawski Y; Sharfman ZT; Amar E; Rath E
J Orthop Case Rep; 2017; 7(1):20-23. PubMed ID: 28630833
[TBL] [Abstract][Full Text] [Related]
27. Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial.
Kölbl O; Knelles D; Barthel T; Raunecker F; Flentje M; Eulert J
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):397-401. PubMed ID: 9788422
[TBL] [Abstract][Full Text] [Related]
28. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.
Neal B; Rodgers A; Dunn L; Fransen M
Cochrane Database Syst Rev; 2000; (3):CD001160. PubMed ID: 10908488
[TBL] [Abstract][Full Text] [Related]
29. Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis.
Zhu XT; Chen L; Lin JH
Medicine (Baltimore); 2018 Aug; 97(31):e11649. PubMed ID: 30075549
[TBL] [Abstract][Full Text] [Related]
30. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty.
Legenstein R; Bösch P; Ungersböck A
Arch Orthop Trauma Surg; 2003 Apr; 123(2-3):91-4. PubMed ID: 12664317
[TBL] [Abstract][Full Text] [Related]
31. Heterotopic Ossification Prophylaxis After Total Hip Arthroplasty: Randomized Trial of 400 vs 700 cGy.
Liu JZ; Frisch NB; Barden RM; Rosenberg AG; Silverton CD; Galante JO
J Arthroplasty; 2017 Apr; 32(4):1328-1334. PubMed ID: 27884418
[TBL] [Abstract][Full Text] [Related]
32. Prevention of heterotopic ossification after total hip replacement with NSAIDs.
Fijn R; Koorevaar RT; Brouwers JR
Pharm World Sci; 2003 Aug; 25(4):138-45. PubMed ID: 12964491
[TBL] [Abstract][Full Text] [Related]
33. Radiation therapy for heterotopic ossification prophylaxis afer high-risk elbow surgery.
Strauss JB; Wysocki RW; Shah A; Chen SS; Shah AP; Abrams RA; Cohen MS
Am J Orthop (Belle Mead NJ); 2011 Aug; 40(8):400-5. PubMed ID: 22016869
[TBL] [Abstract][Full Text] [Related]
34. The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement.
Pakos EE; Tsekeris PG; Paschos NK; Pitouli EJ; Motsis EK; Xenakis TA
J BUON; 2010; 15(1):74-8. PubMed ID: 20414931
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic Celecoxib Administration Is Associated With Decreased Incidence and Severity of Heterotopic Ossification After Hip Resurfacing by Direct Lateral Approach in Male Patients.
Ng M; Brigati D; Wagner TC; Bigart K; Khlopas A; Sultan AA; Mont MA; Brooks P
Orthopedics; 2018 Nov; 41(6):e807-e812. PubMed ID: 30222794
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of NSAIDs versus radiotherapy for heterotopic ossification prophylaxis following total hip arthroplasty in high-risk patients: a systematic review and meta-analysis.
Shapira J; Yelton MJ; Chen JW; Rosinsky PJ; Maldonado DR; Meghpara M; Lall AC; Domb BG
Hip Int; 2022 Sep; 32(5):576-590. PubMed ID: 33736491
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
Macfarlane RJ; Ng BH; Gamie Z; El Masry MA; Velonis S; Schizas C; Tsiridis E
Expert Opin Pharmacother; 2008 Apr; 9(5):767-86. PubMed ID: 18345954
[TBL] [Abstract][Full Text] [Related]
38. Periarticular infiltration in total hip replacement: effect on heterotopic ossification, analgesic requirements and outcome.
Scott CE; Streit J; Biant LC; Breusch SJ
Arch Orthop Trauma Surg; 2012 May; 132(5):703-9. PubMed ID: 22222642
[TBL] [Abstract][Full Text] [Related]
39. [Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].
Kölbl O; Flentje M; Eulert J; Barthel T; Knelles D; Kraus U
Strahlenther Onkol; 1997 Dec; 173(12):677-82. PubMed ID: 9454352
[TBL] [Abstract][Full Text] [Related]
40. Incidence of Heterotopic Ossification with NSAID Prophylaxis Is Low After Open and Arthroscopic Hip Preservation Surgery.
Schaver AL; Willey MC; Westermann RW
Arthrosc Sports Med Rehabil; 2021 Oct; 3(5):e1309-e1314. PubMed ID: 34712968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
